These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32912883)
1. Adult hypophosphatasia manifests in a marathon runner. Fanous N; Barb D BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32912883 [TBL] [Abstract][Full Text] [Related]
2. Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA. Scott LJ BioDrugs; 2016 Feb; 30(1):41-8. PubMed ID: 26832358 [TBL] [Abstract][Full Text] [Related]
3. Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms. Fujisawa Y; Kitaoka T; Ono H; Nakashima S; Ozono K; Ogata T Front Endocrinol (Lausanne); 2020; 11():590455. PubMed ID: 33391183 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trial. Kitaoka T; Tajima T; Nagasaki K; Kikuchi T; Yamamoto K; Michigami T; Okada S; Fujiwara I; Kokaji M; Mochizuki H; Ogata T; Tatebayashi K; Watanabe A; Yatsuga S; Kubota T; Ozono K Clin Endocrinol (Oxf); 2017 Jul; 87(1):10-19. PubMed ID: 28374482 [TBL] [Abstract][Full Text] [Related]
5. Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa. Kishnani PS; Del Angel G; Zhou S; Rush ET Mol Genet Metab; 2021 May; 133(1):113-121. PubMed ID: 33814268 [TBL] [Abstract][Full Text] [Related]
6. Cutis laxa-like calcinosis cutis secondary to asfotase alfa in juvenile-onset hypophosphatasia. Charalambides M; Rooke B; Cain O; Geberhiwot T; Bader E Clin Exp Dermatol; 2020 Dec; 45(8):1103-1105. PubMed ID: 32716093 [No Abstract] [Full Text] [Related]
7. Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels. Koyama H; Yasuda S; Kakoi S; Ohata Y; Shimizu Y; Hasegawa C; Hayakawa A; Akiyama T; Yagi T; Aotani D; Imaeda K; Ozono K; Kataoka H; Tanaka T Intern Med; 2020 Mar; 59(6):811-815. PubMed ID: 31787692 [TBL] [Abstract][Full Text] [Related]
8. Spurious testosterone laboratory results in a patient taking synthetic alkaline phosphatase (asfotase alfa). Sofronescu AG; Ross M; Rush E; Goldner W Clin Biochem; 2018 Aug; 58():118-121. PubMed ID: 29709501 [TBL] [Abstract][Full Text] [Related]
16. Adult hypophosphatasia with compound heterozygous p.Phe327Leu missense and c.1559delT frameshift mutations in tissue-nonspecific alkaline phosphatase gene: a case report. Fukushima K; Kawai-Kowase K; Yonemoto Y; Fujiwara M; Sato H; Sato M; Kubota T; Ozono K; Tamura J J Med Case Rep; 2019 Apr; 13(1):101. PubMed ID: 31014398 [TBL] [Abstract][Full Text] [Related]
17. Asfotase alfa: enzyme replacement for the treatment of bone disease in hypophosphatasia. Hofmann C; Seefried L; Jakob F Drugs Today (Barc); 2016 May; 52(5):271-85. PubMed ID: 27376160 [TBL] [Abstract][Full Text] [Related]
18. Status Epilepticus due to Asfotase Alfa Interruption in Perinatal Severe Hypophosphatasia. Ogawa E; Shimura K; Yoshihashi H; Miyama S Pediatr Neurol; 2022 May; 130():4-6. PubMed ID: 35303588 [TBL] [Abstract][Full Text] [Related]
19. Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia. Bowden SA; Adler BH Osteoporos Int; 2018 Feb; 29(2):511-515. PubMed ID: 29046930 [TBL] [Abstract][Full Text] [Related]
20. [Hypophosphatasia : What is currently available for treatment?]. Schmidt T; Amling M; Barvencik F Internist (Berl); 2016 Dec; 57(12):1145-1154. PubMed ID: 27796472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]